Tag: Prometheus Biosciences
Merck Closes $10.8B Prometheus Biosciences Acquisition
Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the drugmaker’s pursuit of an immunology blockbuster.
In a news release on...
Merck To Buy Prometheus Biosciences In $11B Deal
On Sunday Merck announced it will buy Prometheus Biosciences for about $10.8 billion, building up its presence in immunology.All the shares of Prometheus Biosciences will be acquired by a...
